MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer

Background: To aid in oncology drug development, we investigated MET proto-oncogene receptor tyrosine kinase gene aberrations in 2,239 oncology patients who underwent next-generation sequencing (NGS) in clinical practice. Materials and methods: From November 2019 to January 2021, 2,239 patientswith...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Jihoon, Jung, Jaeyun, Kim, Seung Tae, Hong, Jung Yong, Park, Sehhoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Ahn, Soomin, Kim, Kyoung-Mee, Kang, Won Ki, Lee, Jeeyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722768/
https://www.ncbi.nlm.nih.gov/pubmed/36483096
http://dx.doi.org/10.3389/pore.2022.1610697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722768/
https://www.ncbi.nlm.nih.gov/pubmed/36483096
http://dx.doi.org/10.3389/pore.2022.1610697

Ejemplares similares